UNIVARIATE | MULTIVARIATE | ||||
---|---|---|---|---|---|
Variable | n | OR (95% CI) | p-valuea | OR (95% CI) | p-valuea |
Gender | |||||
Female | 978 | 1.01 (0.68–1.51) | 0.959 | 0.97 (0.56–1.67) | 0.906 |
Male | 108 | 1 | 1 | ||
Age range, years | |||||
≤ 40 | 253 | 1 | 1 | ||
41–50 | 428 | 1.28 (0.94–1.75) | 0.123 | 1.59 (1.04–2.42) | 0.031* |
> 50 | 405 | 1.70 (1. 23–2.34) | 0.001*** | 2.21 (1.41–3.46) | < 0.001*** |
Age of pain onset | |||||
Early, ≤ 3 yrs | 532 | 1 | 1 | ||
Late, > 3 yrs | 520 | 1.44 (1. 12–1.84) | 0.004** | 1.49 (0.75–2.95) | 0.254 |
VAS (fatigue/pain) | |||||
Lower | 645 | 1 | 1 | ||
Higher | 441 | 2.24 (1.73–2.89) | < 0.001*** | 2.09 (1.47–2.97) | < 0.001*** |
Cognitive symptoms | |||||
Severe | 846 | 1 | 1 | ||
Mild/moderate | 61 | 1.66 (1. 30–2.13) | < 0.001*** | 0.28 (0.05–1.64) | 0.159 |
No symptoms | 179 | 0.76 (0.47–1.23) | 0.077** | 0.60 (0. 37-0.96) | 0.033* |
Neurological symptoms | |||||
Severe | 606 | 1 | 1 | ||
Mild/moderate | 451 | 1.66 (1. 30–2.13) | < 0.001*** | 1.37 (0.92–2.04) | 0.117 |
No symptoms | 29 | 0.82 (0.51–1.23) | 0.214 | 11.02 (2. 24–54.29) | 0.003** |
Autonomic dysfunction | |||||
Severe | 412 | 1 | 1 | ||
Mild/moderate | 161 | 2.21 (1.71–2.87) | < 0.001*** | 0.22 (0.03–1.51) | 0.122 |
No symptoms | 513 | 0.81 (0. 37–1.76) | 0.093 | 0.57 (0. 38–0.83) | 0.004** |
Fibromyalgia | |||||
No | 464 | 1 | 1 | ||
Yes | 601 | 1.92 (1.50–2.45) | < 0.001*** | 1.27 (0.87–1.83) | 0.214 |
Ligamentous Hyperlaxity | |||||
No | 719 | 1 | 1 | ||
Yes | 365 | 1.45 (1. 12–1.88) | 0.005** | 1.36 (0.94–1.97) | 0.100 |
SF-36 (physical health) | |||||
Lower | 542 | 1 | 1 | ||
Higher | 541 | 0.48 (0. 38–0.62) | < 0.001*** | 0.45 (0. 31–0.66) | < 0.001*** |
SF-36 (mental health) | |||||
Lower | 542 | 1 | 1 | ||
Higher | 541 | 0.66 (0.52–0.84) | < 0.001*** | 0.50 (0. 33–0.75) | < 0.001*** |
HADS | |||||
No symptoms | 250 | 1 | 1 | ||
Mild/moderate | 583 | 1.82 (1. 35–2.45) | < 0.001*** | 0.90 (0.56–1.44) | 0.667 |
Severe | 240 | 1.86 (1. 30–2.67) | < 0.001*** | 1.98 (1. 20–3.26) | 0.007** |
FIS-40 | |||||
Mild/moderate | 512 | 1 | 1 | ||
Severe | 463 | 2.61 (2.01–3.39) | < 0.001*** | 1.27 (0.82–2.04) | 0.311 |
D-FIS-8 | |||||
Lower fatigue | 563 | 1 | 1 | ||
Higher fatigue | 514 | 2.44 (1.90–3.13) | < 0.001*** | 1.55 (1.08–2.21) | 0.017* |
PSQI | |||||
Good sleepers | 572 | 1 | 1 | ||
Poor sleepers | 446 | 1.47 (1. 14–1.90) | 0.003** | 0.98 (0.66–1.48) | 0.913 |
SCL-90-R | |||||
Mild/moderate | 90 | 1 | 1 | ||
No symptoms | 125 | 1.1 (0.87–1.91) | 0.217 | 1.30 (1. 15–2.73) | 0.571 |
Severe | 430 | 1.98 (1.51–2.61) | < 0.001*** | 1.34 (0.82–2.21) | 0.243 |